Delivery Order SPE2DB22D1103-SPE2DB24FTFM9
Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,350,644 units of the MENQUADFI VIAL 0.5ML pharmaceutical product. The contract has a completion date of January 19, 2024 and a potential value of $4,214.88. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products and medical supplies. The delivery order, valued at $6,038.37, is for the provision of MENQUADFI VIAL 0.5ML and has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,512.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $35,124.00 to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $74,097.05 award is for the supply of 4563225576 ! MENQUADFI VIAL 0.5ML, a pharmaceutical product. The delivery order has a completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a potential value of $2,107.44 and a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of a pharmaceutical product, MENQUADFI VIAL 0.5ML. The contract has a potential value of $2,457.26 and a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not...
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the supply of a pharmaceutical product called MENQUADFI VIAL 0.5ML. The order has a potential value of $5,111.04 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company provides a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,756.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is for the supply of 4564736964 ! MENQUADFI VIAL 0.5ML medical products. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...